- NEWS AND VIEWS
- 22 October 2025
A comprehensive genome analysis suggests that women have more genetic risk variants for major depressive disorder than do men, with stronger links to metabolic traits.
By
-
Na Cai
-
Na Cai is in the Department of Biosystems and Engineering, ETH Zürich, Basel 4056, Switzerland.
-
Major depressive disorder (MDD) affects nearly twice as many women as it does men, but the biological reasons for this disparity are elusive. Writing in Nature Communications, Thomas et al.1 report a meta-analysis of genome-wide association studies (GWASs) — an approach for finding links between genetic variations and observable traits — that includes almost 200,000 men and women with MDD. The researchers’ findings begin to unpick the genetic risk factors that are shared (or not) between men and women, and to explain why subtypes of MDD with metabolic symptoms, such as changes in weight, affect women more than men. Importantly, the results highlight how sex-stratified genetic analyses can help scientists to understand the sex-specific pathology of MDD, which is necessary for guiding more-precise treatments in the future. (This article separates people into ‘male’ and ‘female’ to reflect the use in Thomas and colleagues’ paper, but Nature recognizes that sex and gender are not binary and are not necessarily aligned.)
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
doi: https://doi.org/10.1038/d41586-025-03374-0
References
Thomas, J. T. et al. Nature Commun. 16, 7960 (2025).
Martin, J. et al. Biol. Psychiatry 83, 1044–1053 (2018).
Blokland, G. A. M. et al. Biol. Psychiatry 91, 102–117 (2022).
Silveira, P. P., Pokhvisneva, I., Howard, D. M. & Meaney, M. J. Mol. Psychiatry 28, 2469–2479 (2023).
Howard, D. M. et al. Nature Commun. 9, 1470 (2018).
Kendler, K. S., Gardner, C. O., Gatz, M. & Pedersen, N. L. Psychol. Med. 37, 453–462 (2007).
Kendler, K. S., Gardner, C. O., Neale, M. C. & Prescott, C. A. Psychol. Med. 31, 605–616 (2001).
Cai, N. et al. Nature Genet. 52, 437–447 (2020).
Warrier, V. et al. Lancet Psychiatry 8, 373–386 (2021).
Trubetskoy, V. et al. Nature 604, 502–508 (2022).
Jansen, P. R. et al. Nature Genet. 51, 394–403 (2019).
Okbay, A. et al. Nature Genet. 54, 437–449 (2022).
Venkatesh, S. S. et al. Nature Genet. 57, 1107–1118 (2025).
Oliva, M. et al. Science 369, eaba3066 (2020).
Jones, A. G. et al. Preprint at medRxiv https://doi.org/10.1101/2024.09.03.24313025 (2025).
Zhu, C. et al. Cell Genom. 3, 100297 (2023).
Kendler, K. S. & Gardner, C. O. Br. J. Psychiatry 197, 170–171 (2010).
Competing Interests
The author declares no competing interests.
Related Articles
-
Read the paper: Sex-stratified genome-wide association meta-analysis of major depressive disorder
-
Large study broadens view of the genetic landscape of bipolar disorder
Subjects
Latest on:
-
Four game-changing immunology tools to watch
Nature Index 22 OCT 25
-
The search for mutations that sperm acquire as men age
News & Views 22 OCT 25
-
Gene implicated in the heart defects associated with Down’s syndrome
News & Views 22 OCT 25
.png)
Genetic origins of schizophrenia find common ground
